ImmunityBio (IBRX) Shareholder's Equity (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.66% |
| Dec 31, 2025 | 4.38% |
| Sep 30, 2025 | 8.14% |
| Jun 30, 2025 | 3.50% |
| Mar 31, 2025 | -20.97% |
| Dec 31, 2024 | 34.41% |
| Sep 30, 2024 | -6.71% |
| Jun 30, 2024 | -0.93% |
| Mar 31, 2024 | -17.93% |
| Dec 31, 2023 | -42.69% |
| Sep 30, 2023 | 36.35% |
| Jun 30, 2023 | -21.34% |
| Mar 31, 2023 | -18.21% |
| Dec 31, 2022 | -4.83% |
| Sep 30, 2022 | -1.68% |
| Jun 30, 2022 | -25.01% |
| Mar 31, 2022 | -38.39% |
| Dec 31, 2021 | -28.41% |
| Sep 30, 2021 | -19.77% |
| Jun 30, 2021 | 14.43% |
| Mar 31, 2021 | -56.41% |
| Dec 31, 2020 | -132.01% |
| Sep 30, 2020 | -455.18% |
| Jun 30, 2020 | 169.47% |
| Mar 31, 2020 | -226.77% |
| Dec 31, 2019 | -87.99% |
| Sep 30, 2019 | -10.12% |
| Jun 30, 2019 | -9.86% |
| Mar 31, 2019 | 104.79% |
| Dec 31, 2018 | -49.44% |
| Sep 30, 2018 | -10.76% |
| Jun 30, 2018 | -9.35% |
| Mar 31, 2018 | -8.45% |
| Dec 31, 2017 | -7.93% |
| Sep 30, 2017 | -6.02% |
| Jun 30, 2017 | -9.14% |
| Mar 31, 2017 | -5.13% |
| Dec 31, 2016 | -5.62% |
| Sep 30, 2016 | -5.03% |
| Jun 30, 2016 | -4.98% |
| Mar 31, 2016 | -3.23% |
| Dec 31, 2015 | -1.70% |
| Sep 30, 2015 | 186.23% |